Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NIST Amends Formula Reference Standard With Fatty Acid, Nutrient Additions

This article was originally published in The Tan Sheet

Executive Summary

The National Institute of Standards and Technology revises the substance it provides as a certified reference for analyzing infant and adult formulas to reflect nutritional additives now commonly used

You may also be interested in...



FDA Maintains Miniscule Melamine Levels Pose No Risk

FDA revised its interim safety and risk assessment for the independent presence of melamine or any one of its analogs in infant formula, saying any amount of one such substance below 1 part per million does not raise public health concerns

Martek food growth

The maker of life'sDHA is using the same strategy to expand into the foods and beverage industry that it used to penetrate 99 percent of the U.S. infant formula market. Martek Biosciences President David Abramson tells analysts at the Canaccord Adams Healthy Living Conference Oct. 15 in Boston his firm continues to seek long-term exclusive agreements to supply nutritional oils for conventional foods to market leaders such as Coca-Cola and General Mills. He says Columbia, Md.-based Martek also aims for Splenda-like brand recognition by requiring its partners to highlight life'sDHA on packaging and in ads. Abramson singles out an "exciting" partnership with Dow AgroSciences that would put Martek's oil into a DHA-rich canola oil in development. This month, Martek announced supply deals that will bring its docosahexaenoic and arachidonic fatty acid formulations into Europe and China, whose emerging middle class offers growth opportunity for Martek, Abramson says (1"The Tan Sheet" Oct. 6, 2008, In Brief)

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel